|
Field
Trial Status
|
Before
in_development
|
After
on_going
|
|
Field
Trial End Date
|
Before
June 30, 2025
|
After
March 31, 2026
|
|
Field
Last Published
|
Before
October 04, 2024 07:00 PM
|
After
July 16, 2025 04:57 AM
|
|
Field
Primary Outcomes (End Points)
|
Before
1. Corporate transparency and accounting (CTA) practices
2. Access to finance
3. Firm size and growth
3. Firm practices
|
After
1. Corporate transparency and accounting (CTA) practices
2. Access to finance
3. Firm performance
|
|
Field
Planned Number of Clusters
|
Before
400 firms
|
After
Approximately 400 firms
|
|
Field
Planned Number of Observations
|
Before
400 firms, surveyed at baseline and with multiple follow-up surveys.
|
After
Approximately 400 firms, surveyed at baseline and with multiple follow-up surveys.
|
|
Field
Sample size (or number of clusters) by treatment arms
|
Before
200 treated firms and 200 control firms
|
After
Approximately 200 treated firms and 200 control firms
|